
Cruentus Pharmaceutical Private Limited
About Cruentus Pharmaceutical Private Limited
Data last updated:
Cruentus Pharmaceutical Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24230UP2019PTC112116.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Avnendra Kumar Pal and Madhuresh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 582/298 Badli Khera Manas Nagar, Lucknow, Uttar Pradesh, India – 226012.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.1 Cr, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹1.63 Lakh (net margin 1.5%) and EBITDA of ₹2.13 Lakh (EBITDA margin 1.9%). Revenue has grown at a compounded annual rate (CAGR) of 71% over three years and 54% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Cruentus Pharmaceutical Private Limited's registered office is in Lucknow, Uttar Pradesh.
- Registered Address582/298 Badli Khera Manas Nagar, Lucknow, Uttar Pradesh, India – 226012
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cruentus Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cruentus Pharmaceutical Private Limited, buy the company report.
Financials of Cruentus Pharmaceutical Private Limited
FY 2025 filings availableCruentus Pharmaceutical Private Limited reported revenue of ₹1.1 Cr (up 25% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 54% over five years, including 25% growth in the latest year. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.13 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.63 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.9% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cruentus Pharmaceutical Private Limited, buy the company report.
Board of directors of Cruentus Pharmaceutical Private Limited
Cruentus Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Avnendra Kumar Pal | Director | 09 Jan 2019 | 7 Years 10 Months | Current |
| Madhuresh | Director | 09 Jan 2019 | 7 Years 10 Months | Current |
Peer comparison
Cruentus Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Panchdhan Heights Limited | ₹1.1 Cr (FY 2025) | 144.0% | Kolkata, West Bengal, India | |||
| Shakuntalam Marketing Private Limited | ₹1.1 Cr (FY 2025) | -78.0% | Varanasi, Uttar Pradesh, India | |||
| Nehapandey Farmers Producer Company Limited | ₹1.1 Cr (FY 2025) | 90.0% | Kanpur, Uttar Pradesh, India | |||
| Kenosis Vethealth Private Limited | ₹1.1 Cr (FY 2025) | -11.0% | Ahmedabad, Gujarat, India | |||
| Dynabit Solutions Private Limited | ₹1.1 Cr (FY 2024) | 34.0% | Bangalore, Karnataka, India | |||
| Cruentus Pharmaceutical Private Limitedthis company | ₹1.1 Cr (FY 2025) | ₹1.63 Lakh | 1.5% | 25.0% | Lucknow, Uttar Pradesh, India | |
| Una Hygiene Private Limited | ₹1.1 Cr (FY 2025) | 55.0% | Muvattupuzha, Kerala, India | |||
| Hi-Q Food Products Private Limited | ₹1.1 Cr (FY 2024) | 1.0% | Chennai, Tamil Nadu, India | |||
| Novo Plastics India Private Limited | ₹1.1 Cr (FY 2024) | 24.0% | New Delhi, Delhi, India | |||
| Agaram Infotech Private Limited | ₹1.1 Cr (FY 2025) | -7.0% | Chennai, Tamil Nadu, India | |||
| Avon Agri Fresh Private Limited | ₹1.1 Cr (FY 2018) | 20.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Cruentus Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cruentus Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cruentus Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Cruentus Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Cruentus Pharmaceutical Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Avnendra Kumar Pal was appointed as Director on 09 Jan 2019.
Frequently asked questions
Cruentus Pharmaceutical is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 January 2019 (7+ years old) and is registered under CIN U24230UP2019PTC112116.
Cruentus Pharmaceutical has 2 current directors:
- Avnendra Kumar Pal - Director
- Madhuresh - Director
The latest financial statements of Cruentus Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Cruentus Pharmaceutical is U24230UP2019PTC112116. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cruentus Pharmaceutical was incorporated on 09 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Cruentus Pharmaceutical by revenue are Panchdhan Heights Limited, Shakuntalam Marketing Private Limited, Nehapandey Farmers Producer Company Limited, Kenosis Vethealth Private Limited, Dynabit Solutions Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Avnendra Kumar Pal was appointed as Director on 09 Jan 2019. Madhuresh was appointed as Director on 09 Jan 2019.
The registered office of Cruentus Pharmaceutical is at 582298 Badli Khera Manas Nagar, Lucknow, Uttar Pradesh, India – 226012.
Cruentus Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Cruentus Pharmaceutical is compliant as of 16 September 2026. The company is actively filing with the Registrar of Companies.
Cruentus Pharmaceutical can be reached at its registered office: 582298 Badli Khera Manas Nagar, Lucknow, Uttar Pradesh, India – 226012.

